Pharmacokinetics of enalapril in patients with arterial hypertension depending on the glomerular filtration rate
- Authors: Zhuravleva M.V.1,2, Prokofiev A.B.1,2, Dmitriev A.I.1, Belkov S.A.1, Melnikov E.S.1,2, Rodina T.A.1, Danko A.A.1
-
Affiliations:
- Scientific Center for Expertise of Pharmaceuticals for Medical Use
- Sechenov First Moscow State Medical University (Sechenov University)
- Issue: Vol 10, No 3 (2019)
- Pages: 37-41
- Section: Articles
- URL: https://journals.rcsi.science/2221-7185/article/view/45935
- DOI: https://doi.org/10.26442/22217185.2019.3.190409
- ID: 45935
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Marina V. Zhuravleva
Scientific Center for Expertise of Pharmaceuticals for Medical Use; Sechenov First Moscow State Medical University (Sechenov University)D. Sci. (Med.), Prof Moscow, Russia
Aleksei B. Prokofiev
Scientific Center for Expertise of Pharmaceuticals for Medical Use; Sechenov First Moscow State Medical University (Sechenov University)D. Sci. (Med.), Prof. Moscow, Russia
Artem I. Dmitriev
Scientific Center for Expertise of Pharmaceuticals for Medical Use
Email: dmitriev-doc@mail.ru
Research Officer Moscow, Russia
Sergei A. Belkov
Scientific Center for Expertise of Pharmaceuticals for Medical UseD. Sci. (Med.), Prof. Moscow, Russia
Evgenii S. Melnikov
Scientific Center for Expertise of Pharmaceuticals for Medical Use; Sechenov First Moscow State Medical University (Sechenov University)Cand. Sci. (Pharmaceut.) Moscow, Russia
Tatiana A. Rodina
Scientific Center for Expertise of Pharmaceuticals for Medical UseCand. Sci. (Chemical) Moscow, Russia
Andrei A. Danko
Scientific Center for Expertise of Pharmaceuticals for Medical UseCand. Sci. (Med.) Moscow, Russia
References
- Ezzati M, Lopez A.D, Rodgers A et al. Comparative Risk Assessment Collaborating G. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-60.
- Williams B, Mancia G, Spiering W et al. Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J 2018; 39: 3021-104.
- Chobanian A.V, Bakris G.L, Black H.R et al. Joint National Committee on Prevention DE, Treatment of High Blood Pressure. National Heart L, Blood I, National High Blood Pressure Education Program Coordinating C. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-52.
- Skeggs L.T, Dorer F.E, Kahn J.R et al. The biochemistry of the renin-angiotensin system and its role in hypertension. Am J Med 1976; 60: 737-48.
- Marketou M, Kintsurashvili E, Papanicolaou K.N et al. Cardioprotective effects of a selective B(2) receptor agonist of bradykinin post-acute myocardial infarct. Am J Hypertens 2010; 23: 562-8.
- Van Vark L.C, Bertrand M, Akkerhuis K.M et al. Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158 998 patients. Eur Heart J 2012; 33: 2088-97.
- Thomsen R et al. In vitro drug metabolism by human carboxylesterase 1: focus on angiotensin-converting enzyme inhibitors. Drug Metab Dis 2014; 42 (1): 126-33.
- https://rlsnet.ru.
- Inker L.A, Astor B.C, Fox C.H et al. KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD. Am J Kidney Dis 2014; 63 (5): 713-35.
- Родина Т.А., Мельников Е.С., Соколов А.В. и др. Определение эналаприла и его активного метаболита эналаприлата в плазме крови методом ВЭЖХ-МС/МС при персонализации фармакотерапии больных артериальной гипертензией. Эксперим. и клин. фармакология. 2015; 78 (10): 15-20. @@Rodina T.A., Melnikov E.S., Sokolov A.V. et al. Opredelenie enalaprila i ego aktivnogo metabolita enalaprilata v plazme krovi metodom VEZhKh-MS/MS pri personalizatsii farmakoterapii bol'nykh arterial'noi gipertenziei. Eksperim. i klin. farmakologiia. 2015; 78 (10): 15-20 (in Russian)